Sysmex Inostics
Katharina Wichner is a highly experienced scientist specializing in laboratory operations and immunology. Currently serving as Scientist III at BioAgilytix since February 2022, Wichner has a solid background in the field, having worked as Senior Scientist and Scientist in Laboratory Operations at Sysmex Inostics since January 2015. Previous experience includes a postdoctoral position at the Max Delbrück Center from June 2014 to January 2015, and a PhD student role at the same institution from March 2008 to October 2012. Wichner holds a Dr. rer. nat. in Immunologie and a Diplom-Biologin in Biologie, both from Humboldt-Universität zu Berlin.
This person is not in any offices
Sysmex Inostics
Leaders of the Global Liquid Biopsy Revolution As pioneers in blood-based cell-free tumor DNA (ctDNA) mutation detection, Sysmex Inostics has provided custom assays and CLIA-certified lab services to leading BioPharma companies over the last 10 years with the overall goal: to develop therapeutics that extend lives and provide diagnostics to monitor response to therapy, identify targetable resistance alterations, and detect minimal residual disease (MRD). SafeSEQ NGS technology can detect clinically relevant mutations in circulating tumor DNA (ctDNA) with robust detection as low as 0.03% mutant allele frequency (MAF), thus ensuring reliable molecular information for real-time therapy selection as well as monitoring of tumor response from across a broader range of genomic regions.